Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

This publication has 10 references indexed in Scilit:

• Yellow fever vaccine
  Published by Elsevier ,2013
• Immunogenicity of Live Attenuated SA14–14–2 Japanese Encephalitis Vaccine—A Comparison of 1–and 3‐Month Immunization Schedules
  The Journal of Infectious Diseases, 1998
• Short‐Term Safety of Live Attenuated Japanese Encephalitis Vaccine (SA14–14–2): Results of a Randomized Trial with 26,239 Subjects
  The Journal of Infectious Diseases, 1997
• Allergic mucocutaneous reactions to Japanese encephalitis vaccine
  Vaccine, 1997
• Systemic Reactions in U.S. Marine Corps Personnel Who Received Japanese Encephalitis Vaccine
  Clinical Infectious Diseases, 1997
• Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study
  The Lancet, 1996
• Nucleotide and deduced amino acid sequence of the structural protein genes of Japanese encephalitis viruses from different geographical locations
  Journal of General Virology, 1995
• Evaluation of the Potency and Safety of Inactivated Japanese Encephalitis Vaccine in US Inhabitants
  The Journal of Infectious Diseases, 1990
• Safety of a Live-Attenuated Japanese Encephalitis Virus Vaccine (SA14-14-2) for Children
  The American Journal of Tropical Medicine and Hygiene, 1988
• Kinetics of IgM and IgG Responses to Japanese Encephalitis Virus in Human Serum and Cerebrospinal Fluid
  The Journal of Infectious Diseases, 1985